Quarterly report · Q2
4548.TEDINET S100SALX
Period2023-04-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥18.1bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥33.5bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥17.3bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥1.5bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥2.6bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥2.3bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥3.1bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.6bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥2.3bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥3.6bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.1bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.2bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.1bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥2.1bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥3.1bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥79.6bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥75.6bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥77.8bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥8.1bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥8.4bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥71.5bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥67.2bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥69.8bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥18.0bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥23.5bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥21.0bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥25.8bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥24.4bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥23.4bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥490m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥268m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥4.6bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥3.4bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥1.3bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥731m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.9bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥38.54 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥3.93 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥40.49 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥56.32 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥29.72 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 89.9% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.9% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.6% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 18
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E00970-000LALreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥5.0bn |
| jpcrp040300-q2r_E00970-000LALreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥5.0bn |
| jpcrp040300-q2r_E00970-000LALreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥420m |
| jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥13.1bn |
| jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥13.1bn |
| jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥1.1bn |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥18.1bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥18.1bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥1.5bn |
| jpcrp040300-q2r_E00970-000LALreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥5.6bn |
| jpcrp040300-q2r_E00970-000LALreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥5.6bn |
| jpcrp040300-q2r_E00970-000LALreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥1.4bn |
| jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥11.7bn |
| jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥11.7bn |
| jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥1.2bn |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥17.3bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥17.3bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥2.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 525
| Item | Context | Value | Unit |
|---|---|---|---|
| Interest expenses ope cf | Prior1YTDDuration | 3000000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 2000000 | JPY |
| Business structure improvement expenses ope cf | Prior1YTDDuration | － | JPY |
| Business structure improvement expenses ope cf | CurrentYTDDuration | 29000000 | JPY |
| Foreign exchange losses gains ope cf | Prior1YTDDuration | -869000000 | JPY |
| Foreign exchange losses gains ope cf | CurrentYTDDuration | -532000000 | JPY |
| Loss gain on sales of investment securities ope cf | Prior1YTDDuration | -4000000 | JPY |
| Loss gain on sales of investment securities ope cf | CurrentYTDDuration | 0 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | -1118000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | -2029000000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | -5000000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | -173000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | 183000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | 197000000 | JPY |
| Decrease increase in consumption taxes receivable payable ope cf | Prior1YTDDuration | -195000000 | JPY |
| Decrease increase in consumption taxes receivable payable ope cf | CurrentYTDDuration | 293000000 | JPY |
| Increase decrease in accounts payable other ope cf | Prior1YTDDuration | -1121000000 | JPY |
| Increase decrease in accounts payable other ope cf | CurrentYTDDuration | -1055000000 | JPY |
| Other net ope cf | Prior1YTDDuration | -338000000 | JPY |
| Other net ope cf | CurrentYTDDuration | -130000000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | 481000000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | -562000000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 194000000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 255000000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -3000000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -2000000 | JPY |
| Income taxes paid refund ope cf | Prior1YTDDuration | -405000000 | JPY |
| Income taxes paid refund ope cf | CurrentYTDDuration | -181000000 | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration | 268000000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | -490000000 | JPY |
| Payments into time deposits inv cf | Prior1YTDDuration | -515000000 | JPY |
| Payments into time deposits inv cf | CurrentYTDDuration | -1000000000 | JPY |
| Proceeds from withdrawal of time deposits inv cf | Prior1YTDDuration | 611000000 | JPY |
| Proceeds from withdrawal of time deposits inv cf | CurrentYTDDuration | 536000000 | JPY |
| Purchase of short term investment securities inv cf | Prior1YTDDuration | -1999000000 | JPY |
| Purchase of short term investment securities inv cf | CurrentYTDDuration | -2499000000 | JPY |
| Proceeds from redemption of securities inv cf | Prior1YTDDuration | 4353000000 | JPY |
| Proceeds from redemption of securities inv cf | CurrentYTDDuration | 2700000000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YTDDuration | -973000000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -2071000000 | JPY |
| Purchase of intangible assets inv cf | Prior1YTDDuration | -110000000 | JPY |
| Purchase of intangible assets inv cf | CurrentYTDDuration | -47000000 | JPY |
| Purchase of investment securities inv cf | Prior1YTDDuration | － | JPY |
| Purchase of investment securities inv cf | CurrentYTDDuration | -2200000000 | JPY |
| Proceeds from sales of investment securities inv cf | Prior1YTDDuration | 8000000 | JPY |
| Proceeds from sales of investment securities inv cf | CurrentYTDDuration | 1000000 | JPY |
| Other net inv cf | Prior1YTDDuration | -36000000 | JPY |
| Other net inv cf | CurrentYTDDuration | 2000000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | 1338000000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -4578000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |